上海三友医疗器械股份有限公司关于向2025年限制性股票激励计划激励对象授予限制性股票的公告

Core Viewpoint - Shanghai Sanyou Medical Instruments Co., Ltd. has announced the granting of restricted stock to 55 eligible participants under its 2025 Restricted Stock Incentive Plan, with a total of 4.782 million shares to be granted at a price of 11.12 yuan per share, representing 1.43% of the company's total share capital as of the announcement date [2][10][24]. Summary by Sections Restricted Stock Grant Details - Grant Date: September 26, 2025 [10] - Total Shares Granted: 4.782 million shares [10] - Grant Price: 11.12 yuan per share [10] - Number of Eligible Participants: 55 [10] Decision-Making Process - The decision to grant restricted stock was approved during the fourth board meeting on September 26, 2025, following prior approvals from the compensation and assessment committee and the shareholders' meeting [3][4][24]. - The internal announcement of the eligible participants took place from August 25 to September 3, 2025, with no objections received [3]. Compliance with Regulations - The granting of restricted stock complies with the relevant regulations, including the "Management Measures for Equity Incentives of Listed Companies" [7][19]. - The board confirmed that both the company and the eligible participants met all necessary conditions for the grant [8][15]. Accounting and Financial Impact - The fair value of the restricted stock will be calculated using the Black-Scholes model, with the stock price at the grant date set at 19.84 yuan per share [16][17]. - The estimated impact on the company's net profit due to the stock incentive plan will be recognized as an expense over the vesting period [18]. Legal and Financial Advisory Opinions - Legal opinions confirm that the granting of restricted stock has received the necessary approvals and complies with applicable laws and regulations [19][20]. - Independent financial advisors have also validated that the granting conditions have been met and are in accordance with relevant legal frameworks [20].